Etiqueta: Review

Europe's top car manufacturer Volkswagen presented a series of more affordable electric vehicles Monday as Chinese EV titan BYD said it would start producing a cut-price model on the continent. With starting prices of around 25,000 euros ($29,000), lower than many current EVs made by European manufacturers, their commercial launch is set for next year.

Europe's top car manufacturer Volkswagen on Monday presented a series of more affordable electric vehicles to take on fast-growing Chinese rivals as Germany's troubled auto sector seeks to turn around its fortunes.Their commercial launch is set for 2026, VW said in a statement, and is part of efforts to combat Chinese carmakers which are gaining market share in Europe with their own affordable EVs.  Volkswagen says it has made considerable cost savings on the cars by sharing technology across th

The fight for the most popular family-sized all-electric SUV isn't even close between the BYD Sealion 7 and Tesla Model Y.

MUNICH (Reuters) -Major automakers will showcase their latest models at Munich's car show on Monday as Europe's automotive sector faces crises ranging from U.S. tariff hikes to costly electrification and the expansion of Chinese automakers on their home turf. Aside from a product blitz to counter Chinese models being pushed to European consumers, including by BYD, Changan and GAC, domestic firms will focus on lobbying to persuade the European Union to reconsider its 2035 ban on combustion-engine cars. Attention will also be on U.S. President Donald Trump's tariffs on European-made cars.

Time to compare three chart-topping family PHEVs on price, practicality and comfort

The battle of the compact electric saloons is heating up – which EV comes out on top?

Targeting the Kia EV3 and Hyundai Kona Electric, the first deliveries of the new BYD Atto 2 are expected next month.

India aims to transition from a global pharmacy to an innovation hub by reforming its regulatory landscape. The focus is on AI-powered approvals, adaptive trials, fast-track pathways, and a single-window digital platform. Creating public market access for biotech startups and incentivizing investment are crucial to compete with China's advancements in drug innovation.